The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine

被引:45
作者
Davis, MP [1 ]
Homsi, J [1 ]
机构
[1] Cleveland Clin Fdn, Harry R Horvitz Ctr Palliat Med, Cleveland, OH 44195 USA
关键词
CYP2D6; palliative medicine; drug metabolism; drug interactions; ethnic differences; pharmacokinetics;
D O I
10.1007/s005200000222
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The enzymes in the cytochrome p450 monooxygenase system (CYP) are the major enzymes responsible for metabolizing medications. The CYP2D6 isomer is responsible for metabolizing certain opioids, neuroleptics, antidepressants and cardiac medications. Owing to CYP2D6's low capacity and high affinity it is easily saturated by substrate and/or inhibited, resulting in pharmacokinetic interactions. Polymorphisms of the structural gene are common, leading to wide inter-individual and ethnic differences in drug metabolism. Clinically important drug interactions, which may be anticipated in the palliative medicine population, are reviewed.
引用
收藏
页码:442 / 451
页数:10
相关论文
共 105 条
[31]  
Gibbs MA, 1999, DRUG METAB DISPOS, V27, P180
[32]   The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin [J].
Gorski, JC ;
Jones, DR ;
Haehner-Daniels, BD ;
Hamman, MA ;
O'Mara, EM ;
Hall, SD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (02) :133-143
[33]  
GORSKI JC, 1994, BIOCHEM PHARMACOL, V47, P1643
[34]   Drug interactions and anti-infective therapies [J].
Gregg, CR .
AMERICAN JOURNAL OF MEDICINE, 1999, 106 (02) :227-237
[35]  
Guengerich F P, 1997, Adv Pharmacol, V43, P7, DOI 10.1016/S1054-3589(08)60200-8
[36]   On the assessment of drug metabolism by assays of codeine and its main metabolites [J].
Haffen, E ;
Paintaud, G ;
Berard, M ;
Masuyer, C ;
Bechtel, Y ;
Bechtel, PR .
THERAPEUTIC DRUG MONITORING, 2000, 22 (03) :258-265
[37]   Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype [J].
Haffen, E ;
Vandel, P ;
Broly, F ;
Vandel, S ;
Sechter, D ;
Bizouard, P ;
Bechtel, PR .
PHARMACOPSYCHIATRY, 1999, 32 (06) :232-234
[38]   Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity [J].
Hamelin, BA ;
Bouayad, A ;
Méthot, J ;
Jobin, J ;
Desgagnés, P ;
Poirier, P ;
Allaire, J ;
Dumesnil, J ;
Turgeon, J .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (05) :466-477
[39]  
Hamilton RA, 1998, PHARMACOTHERAPY, V18, P1112
[40]   Increased bioavailability of oral melatonin after fluvoxamine coadministration [J].
Härtter, S ;
Grözinger, M ;
Weigmann, H ;
Röschke, J ;
Hiemke, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (01) :1-6